Amylyx Pharmaceuticals Voluntarily Withdraws ALS Drug
'Relyvrio' is a prescription medicine used to treat adults with ALS. As of Thursday, it will no longer be available for new patients.
Amylyx Pharmaceuticals announced it has started the process of voluntarily pulling its ALS drug from the market. ‘Relyvrio’ is a prescription medicine used to treat adults with ALS. As of Thursday, it will no longer be available for new patients. Those who are currently on therapy who, in consultation with their physician, wish to stay on treatment can transition to…